The Rise of Local Development Hubs in the U.S.

Food companies are moving beyond the stage of simply increasing overseas sales and shifting their center of gravity toward systems in which they directly plan and test products in local markets. Samyang Foods, for example, is expanding its U.S. subsidiary from a sales outpost into a development and validation hub, driven by growth in the American market. The fact that sales at its U.S. subsidiary reached 595.2 billion won has provided the backdrop for this transition.

This change has broader structural significance than simply increasing exports of one or two products. It is an attempt to expand into categories beyond ramen using already established distribution networks, and a strategy to reduce the cost of failure by quickly reflecting local consumer tastes.

Capital and Research Flow Into More Segmented Health Needs

In the health functional food market, product development is increasingly focused less on general-purpose products and more on targeting specific symptoms and lifestyle discomforts such as sleep, blood sugar, menopause, prostate health, and memory. While the domestic health supplement market grew to 5.9626 trillion won but saw slowing growth, a sleep-solution startup raised 4 billion won in a Series A investment round, and a functional ingredient company secured a total of 3 billion won in R&D support over three years, showing that capital is moving into specialized functional segments.

This trend is less a passing fad than a sign that the nature of ingredient competition is changing. As domestic agricultural-material-based ingredients such as a compound extract of Korean angelica and astragalus and gastrodia attempt to enter the market after undergoing human application trials and receiving functional recognition, a structure is being reinforced in which regional agriculture, research institutions, and companies work together to create high-value-added ingredients.

Patents and Ingredient Recognition Become Barriers to Entry

Companies are now focusing, even before selling finished products, on building foundational assets such as patents, strains, functional ingredients, and cultivation technologies. Huons affiliates’ formulation patents, hy’s library of 5,096 microbial strains, and Cosmax’s expanded cultivation and application of ingredients all reflect efforts to secure the groundwork needed to broaden product lines later.

This is because as markets become more saturated, it becomes harder to differentiate on brand alone. Companies need a combination of ingredient standardization and exclusivity, clinical evidence, and supply chain control to avoid price competition and maintain leadership in overseas expansion or follow-up product development.

Growing Verification Pressure Alongside Growth Expectations

Behind market expansion, oversight gaps and business risks are also growing. This year alone, 180 cases of unfair advertising related to weight loss were caught, reports of adverse events involving health functional foods over recent years reached a total of 18,693 cases, and there was even a confirmed case in which ingredients imported in the form of ordinary food were found to contain up to 1,500 times more aloin.

From the corporate perspective as well, not every new business leads to results. There are cases where expansion strategies have faltered, such as Woongjin Foods, where Darilhan was discontinued. Some companies are also experiencing delays because approval for individually recognized ingredients has not been granted, while biotech companies are turning to the health supplement business as a new source of revenue to fill the long gap in new drug development. Ultimately, the current market can be seen as a phase in which greater opportunity also demands evidence, regulatory responsiveness, and proof of profitability at the same time.